Tuesday, 02 January 2024 12:17 GMT

Statewide Practice Strengthens Presence In Rapidly Growing Wesley Chapel Community


(MENAFN- PR Newswire)

Dr. Hasanein earned his medical degree from the University of Damascus School of Medicine in Syria. He completed internal medicine residency training at Brookdale University Hospital in Brooklyn, New York and was named as chief fellow during his fellowship training in oncology/hematology at the University of Missouri in Columbia.

"We continue to expand our team of medical oncologists who share a passion for community oncology and an impressive record of involvement with medical research that is contributing to exciting advancements in patient care, said David Wenk, MD , FCS assistant managing physician." "Dr. Hasanein is an excellent addition to our statewide practice."

Once open, the new FCS Wesley Chapel location will boast two stories, 45,000 square feet total, and will include 27 patient exam rooms, 69 infusion treatment chairs, as well as an on-site laboratory, pharmacy, PET/CT imaging, and radiation oncology services. Patients will also have opportunities to participate in clinical trials research and care coordination services.

About Florida Cancer Specialists & Research Institute, LLC: (FLCancer)
For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its robust clinical research program.

FCS provides patients with access to a wide range of clinical trials, positioning it as a leader in research among private oncology practices in Florida and across the country. In fact, before receiving FDA approval, the majority of new cancer drugs in the U.S. were first made available to patients through participation in clinical trials at FCS.

Our outstanding team of highly trained and dedicated physicians is committed to delivering tailored treatment plans that make the best use of cutting-edge precision oncology advancements to enhance patient outcomes.

SOURCE Florida Cancer Specialists & Research Institute

MENAFN28012025003732001241ID1109139792



PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search